Sugi Predict

Sugi Predict / Compounds / SCHEMBL29375573

SCHEMBL29375573

SCHEMBL29375573

Nc1nc2c(ncn2[C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@H]2O)c(=O)[nH]1

nearest known ligand 0.73

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ FUT5 Q11128 1/20 0.73
▸ TGM2 P21980 1/20 0.71
▸ KRAS P01116 2/20 0.67
▸ NT5E P21589 1/20 0.67
▸ P2RY6 Q15077 7/20 0.63
▸ P2RY2 P41231 6/20 0.63
▸ P2RY4 P51582 5/20 0.63
▸ P2RX3 P56373 1/20 0.62
▸ P2RY14 Q15391 6/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29527687 1.00 FUT5 (0.73) FUT5TGM2KRASNT5EP2RY6
SCHEMBL30646153 1.00 FUT5 (0.73) FUT5TGM2KRASNT5EP2RY6
SCHEMBL29393705 1.00 FUT5 (0.73) FUT5TGM2KRASNT5EP2RY6
SCHEMBL29456613 1.00 FUT5 (0.73) FUT5TGM2KRASNT5EP2RY6
SCHEMBL30973673 1.00 FUT5 (0.73) FUT5TGM2KRASNT5EP2RY6
SCHEMBL29351374 1.00 FUT5 (0.73) FUT5TGM2KRASNT5EP2RY6
SCHEMBL29581866 1.00 FUT5 (0.73) FUT5TGM2KRASNT5EP2RY6
SCHEMBL29391942 1.00 FUT5 (0.73) FUT5TGM2KRASNT5EP2RY6
SCHEMBL29368655 0.99 FUT5 (0.72) FUT5TGM2KRASNT5EP2RY6
SCHEMBL25899459 0.94 FUT5 (0.73) FUT5TGM2KRASNT5EP2RY6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026100273-A1 METHOD FOR PRODUCING USEFUL SUBSTANCE, CULTURE SOLUTION FOR CULTURING ALGAE, APPARATUS FOR PRODUCING USEFUL SUBSTANCE, AND ALGAE CONTAINING USEFUL SUBSTANCE ＮＴＴ株式会社 2026-05-15 — — WO claimed
US-20260002136-A1 ENGINEERED GLYCOSYLTRANSFERASES AND STEVIOL GLYCOSIDE GLUCOSYLATION METHODS TATE & LYLE SOLUTIONS USA LLC (US) 2026-01-01 — — US claimed
US-12454682-B2 Engineered glycosyltransferases and steviol glycoside glucosylation methods TATE & LYLE SOLUTIONS USA LLC (US) 2025-10-28 — — US claimed
US-12404499-B2 Engineered glycosyltransferases and steviol glycoside glucosylation methods TATE & LYLE SOLUTIONS USA LLC (US) 2025-09-02 — — US claimed
US-12291728-B2 Engineered glycosyltransferases and steviol glycoside glucosylation methods TATE & LYLE SOLUTIONS USA LLC (US) 2025-05-06 — — US claimed
CN-119731313-A Preparation method and application of fucose and intermediates thereof 北京国科星联科技有限公司 2025-03-28 — — CN claimed
WO-2025040179-A1 PREPARATION METHOD FOR REBAUDIOSIDE M, AND USE OF β-1,2-GLUCOSYLTRANSFERASE IN SAME 弈柯莱生物科技(集团)股份有限公司 2025-02-27 — — WO claimed
CN-119506239-A Preparation method of rebaudioside M and application of beta-1, 2-glucosyltransferase in rebaudioside M 弈柯莱生物科技(集团)股份有限公司 2025-02-25 — — CN claimed
WO-2025036155-A1 PREPARATION METHOD FOR AND USE OF FUCOSE AND INTERMEDIATE THEREOF 北京国科星联科技有限公司 2025-02-20 — — WO claimed
CN-118956802-A Engineered glycosyltransferases and sweeteners method for glucosylation of chrysanthenol glycosides 泰莱解决方案美国有限责任公司 2024-11-15 — — CN claimed
US-20230346831-A1 METHODS FOR TREATING METASTATIC CANCER USING LOW DOSE CARBON MONOXIDE CORNELL UNIVERSITY (US) 2023-11-02 — — US claimed
US-11760981-B2 Engineered glycosyltransferases and steviol glycoside glucosylation methods CODEXIS, INC. (US) 2023-09-19 — — US claimed
CN-114283069-B Brain magnetic resonance image super-resolution reconstruction method 卡乐福医疗科技集团有限公司 2023-06-23 — — CN claimed
CN-112760301-B Glycosyl transferase mutant with improved catalytic activity and application thereof 中国科学院天津工业生物技术研究所 2023-01-17 — — CN claimed
US-20220306998-A1 ENGINEERED GLYCOSYLTRANSFERASES AND STEVIOL GLYCOSIDE GLUCOSYLATION METHODS TATE & LYLE SOLUTIONS USA LLC 2022-09-29 — — US claimed
CN-111424065-B Method for glycosylating stevioside compounds by using glycosyltransferase 金禾益康(北京)生物科技有限公司 2022-08-16 — — CN claimed
US-20220228186-A1 COMPOSITIONS AND METHODS FOR PRODUCING STEVIOL GLYCOSIDES ARZEDA CORP. 2022-07-21 — — US claimed
CN-109312379-B Multifunctional recombinant nucleotide-dependent glycosyltransferase protein and glycosylation method thereof 科学与工业研究委员会 2022-04-12 — — CN claimed
CN-114283069-A Brain magnetic resonance image super-resolution reconstruction method 柚皮(重庆)科技有限公司 2022-04-05 — — CN claimed
EP-3973069-A1 COMPOSITIONS AND METHODS FOR PRODUCING STEVIOL GLYCOSIDES Arzeda Corp. (US) 2022-03-30 — — EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260002136-A1 ENGINEERED GLYCOSYLTRANSFERASES AND STEVIOL GLYCOSIDE GLUCOSYLATION METHODS UGGT1, UGCG, COASY FUT5 59/4885TGM2 2000/4885KRAS 2695/4885
US-12454682-B2 Engineered glycosyltransferases and steviol glycoside glucosylation methods UGGT1, GBA3, UGCG FUT5 24/4885TGM2 816/4885KRAS 3348/4885
US-11760981-B2 Engineered glycosyltransferases and steviol glycoside glucosylation methods UGGT1, GBA3, UGCG FUT5 24/4885TGM2 816/4885KRAS 3348/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.